Willem J.M. Dewilde

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

Willem J.M. Dewilde, Tom Oirbans, Freek W.A. Verheugt et al. · The Lancet · 2013 · 1.7K citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +11

A Genotype-Guided Strategy for Oral P2Y ₁₂ Inhibitors in Primary PCI

Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine · 2019 · 597 citations · Full text

CYP2C19 genotype–guided antiplatelet therapy in ST-segment elevation myocardial infarction patients—Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics study

Thomas O. Bergmeijer, Paul W.A. Janssen, Jurjan C. Schipper et al. · American Heart Journal · 2014 · 81 citations

Thrombosis, Percutaneous Coronary Intervention, Antiplatelet Therapy +12

Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial

Willem J.M. Dewilde, Paul W.A. Janssen, Johannes C. Kelder et al. · EuroIntervention · 2015 · 50 citations

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial

Daniel M.F. Claassens, Pim W. M. van Dorst, Gerrit J.A. Vos et al. · American Journal of Cardiovascular Drugs · 2021 · 27 citations · Full text

Epidemiology, Cardiovascular Disease, Popular Genetics Trial +10